S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
pixel
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
pixel
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
pixel
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
pixel
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
pixel
NASDAQ:DCTH

Delcath Systems - DCTH Stock Forecast, Price & News

$4.36
+0.20 (+4.81%)
(As of 08/5/2022 08:48 PM ET)
Add
Compare
Today's Range
$4.21
$4.40
50-Day Range
$3.62
$4.61
52-Week Range
$3.49
$11.95
Volume
12,400 shs
Average Volume
28,354 shs
Market Capitalization
$34.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.67

Delcath Systems MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
396.9% Upside
$21.67 Price Target
Short Interest
Healthy
3.59% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.21mentions of Delcath Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$294,613 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($3.15) to ($1.53) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

294th out of 1,283 stocks

Surgical & Medical Instruments Industry

28th out of 130 stocks

DCTH stock logo

About Delcath Systems (NASDAQ:DCTH) Stock

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Analysts Set New Price Targets

Several equities analysts recently weighed in on DCTH shares. Canaccord Genuity Group cut their target price on shares of Delcath Systems from $24.00 to $20.00 and set a "buy" rating for the company in a research note on Monday, April 11th. BTIG Research decreased their price objective on shares of Delcath Systems from $23.00 to $20.00 and set a "buy" rating for the company in a research note on Friday, June 24th. Finally, StockNews.com assumed coverage on shares of Delcath Systems in a research note on Monday, August 1st. They issued a "sell" rating for the company.

Delcath Systems Price Performance

Delcath Systems stock traded up $0.20 during midday trading on Friday, reaching $4.36. The company's stock had a trading volume of 12,462 shares, compared to its average volume of 29,654. Delcath Systems has a fifty-two week low of $3.49 and a fifty-two week high of $11.95. The company has a debt-to-equity ratio of 2.55, a quick ratio of 2.70 and a current ratio of 2.93. The stock's 50 day simple moving average is $4.06 and its 200 day simple moving average is $5.44. The firm has a market capitalization of $34.49 million, a PE ratio of -1.21 and a beta of 0.93.

Delcath Systems (NASDAQ:DCTH - Get Rating) last released its quarterly earnings results on Tuesday, May 10th. The company reported ($1.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.84) by ($0.16). Delcath Systems had a negative return on equity of 246.07% and a negative net margin of 764.84%. The firm had revenue of $0.38 million for the quarter, compared to analyst estimates of $1.26 million. During the same period last year, the firm earned ($1.04) EPS. On average, equities research analysts forecast that Delcath Systems will post -3.15 earnings per share for the current year.

Insider Activity at Delcath Systems

In other news, CEO Gerard J. Michel bought 62,814 shares of the business's stock in a transaction that occurred on Wednesday, July 20th. The stock was purchased at an average price of $3.98 per share, with a total value of $249,999.72. Following the purchase, the chief executive officer now owns 125,864 shares of the company's stock, valued at approximately $500,938.72. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Steven A. J. Salamon bought 6,000 shares of the firm's stock in a transaction dated Thursday, May 12th. The stock was acquired at an average price of $4.90 per share, for a total transaction of $29,400.00. Following the acquisition, the director now owns 29,424 shares of the company's stock, valued at $144,177.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Gerard J. Michel purchased 62,814 shares of the firm's stock in a transaction on Wednesday, July 20th. The stock was bought at an average price of $3.98 per share, with a total value of $249,999.72. Following the acquisition, the chief executive officer now owns 125,864 shares in the company, valued at $500,938.72. The disclosure for this purchase can be found here. In the last quarter, insiders bought 72,114 shares of company stock valued at $294,613. 16.76% of the stock is owned by insiders.

Receive DCTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Delcath Systems and its competitors with MarketBeat's FREE daily newsletter.

DCTH Stock News Headlines

Earnings Outlook For Delcath Systems
Delcath Systems Q1 2022 Earnings Preview
Delcath Systems to Host First Quarter 2022 Results
See More Headlines
Receive DCTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Delcath Systems and its competitors with MarketBeat's FREE daily newsletter.

DCTH Company Calendar

Last Earnings
5/10/2022
Today
8/08/2022
Next Earnings (Estimated)
8/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DCTH
Employees
55
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$21.67
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+396.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-25,650,000.00
Net Margins
-764.84%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.56 million
Book Value
$1.62 per share

Miscellaneous

Free Float
6,582,000
Market Cap
$34.47 million
Optionable
Not Optionable
Beta
0.93














DCTH Stock - Frequently Asked Questions

Should I buy or sell Delcath Systems stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Delcath Systems in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Delcath Systems stock.
View analyst ratings for Delcath Systems
or view top-rated stocks.

What is Delcath Systems' stock price forecast for 2022?

3 Wall Street research analysts have issued 12-month target prices for Delcath Systems' stock. Their DCTH stock forecasts range from $20.00 to $25.00. On average, they expect Delcath Systems' share price to reach $21.67 in the next year. This suggests a possible upside of 396.9% from the stock's current price.
View analysts' price targets for Delcath Systems
or view top-rated stocks among Wall Street analysts.

How has Delcath Systems' stock performed in 2022?

Delcath Systems' stock was trading at $7.75 at the beginning of the year. Since then, DCTH shares have decreased by 43.7% and is now trading at $4.36.
View the best growth stocks for 2022 here
.

When is Delcath Systems' next earnings date?

Delcath Systems is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022.
View our earnings forecast for Delcath Systems
.

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (NASDAQ:DCTH) issued its quarterly earnings results on Tuesday, May, 10th. The company reported ($1.00) earnings per share for the quarter, missing analysts' consensus estimates of ($0.84) by $0.16. The business had revenue of $0.38 million for the quarter, compared to analyst estimates of $1.26 million. Delcath Systems had a negative net margin of 764.84% and a negative trailing twelve-month return on equity of 246.07%. During the same period last year, the business posted ($1.04) EPS.

When did Delcath Systems' stock split? How did Delcath Systems' stock split work?

Delcath Systems's stock reverse split on Tuesday, October 22nd 2019. The 1-100 reverse split was announced on Friday, October 18th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 21st 2019. An investor that had 100 shares of Delcath Systems stock prior to the reverse split would have 1 shares after the split.

What is Delcath Systems' stock symbol?

Delcath Systems trades on the NASDAQ under the ticker symbol "DCTH."

How do I buy shares of Delcath Systems?

Shares of DCTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Delcath Systems' stock price today?

One share of DCTH stock can currently be purchased for approximately $4.36.

How much money does Delcath Systems make?

Delcath Systems (NASDAQ:DCTH) has a market capitalization of $34.47 million and generates $3.56 million in revenue each year. The company earns $-25,650,000.00 in net income (profit) each year or ($3.59) on an earnings per share basis.

How many employees does Delcath Systems have?

Delcath Systems employs 55 workers across the globe.

How can I contact Delcath Systems?

Delcath Systems' mailing address is 1633 BROADWAY SUITE 22C, NEW YORK NY, 10019. The official website for Delcath Systems is delcath.com. The company can be reached via phone at 212-489-2100, via email at investorrelations@delcath.com, or via fax at 212-489-2102.

This page (NASDAQ:DCTH) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.